Cargando…
T53. USING ARTIFICIAL INTELLIGENCE PLATFORMS TO ENHANCE STUDY DESIGN IN SCHIZOPHRENIA TRIALS
BACKGROUND: Remote patient monitoring is critical in ensuring optimal drug exposure. Between 30–50% of CNS trials fail because patients are not following the assigned protocol. It is estimated that non-adherence based on pharmacokinetic (PK) data is as high as 39% in schizophrenia trials. An AI plat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887427/ http://dx.doi.org/10.1093/schbul/sby016.329 |